Article
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir.
Antimicrobial agents and chemotherapy - 1 Sept 2007
Masse Sherie, Lu Xiaozhi, Dekhtyar Tatyana, Lu Liangjun, Koev Gennadiy, Gao Feng, Mo Hongmei, Kempf Dale, Bernstein Barry, Hanna George J, Molla Akhteruzzaman
Abstract excerpt
Lopinavir (LPV)-ritonavir has demonstrated durable antiviral activity in human immunodeficiency virus type 1 (HIV-1)-infected antiretroviral-naïve and protease inhibitor (PI)-experienced patients. However, information on LPV activity against HIV-2 and the patterns of mutations in HIV-2 in response to selection by LPV is limited. The activity of LPV against three strains of HIV-2 was assessed and compared to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
